Skip to main content
SpringerLink
Log in

Surgical Management of Intrahepatic Cholangiocarcinoma

  • Chapter
  • First Online:
The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases

  • 1915 Accesses

Abstract

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer, accounting for 10–15% of primary hepatic malignancy. Currently, liver resection is still the most effective treatment for ICC patients to achieve adequate long-term survival, although its overall efficacy may not be as good as that for hepatocellular carcinoma (HCC) patients due to the unique pathogenesis and clinical-pathological profiles of ICC.

Adequate preoperative evaluation of the patients is essential and it mainly focuses on establishing the diagnosis of ICC, rather than other metastatic adenocarcinoma from other primary tumors, and assessment of the suitability of the patient and the tumor for operation. Thorough evaluation should include a detailed history, physical examination, assessment of comorbid conditions, assessment of hepatic function, measurement of tumor markers, and radiologic imaging to assess the extent of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wang K, Zhang H, Xia Y, et al. Surgical options for intrahepatic cholangiocarcinoma. Hepatobil Surg Nutr. 2017;6(2):79.

    Article  Google Scholar 

  2. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84–96.

    Article  PubMed  Google Scholar 

  3. Tabrizian P, Jibara G, Hechtman JF, et al. Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford). 2015;17:344–51.

    Article  Google Scholar 

  4. Brown KM, Parmar AD, Geller DA, et al. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2014;23:231–46.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Patel T, Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol. 2007;23:317–23.

    Article  PubMed  Google Scholar 

  6. Alvaro D. Serum and bile biomarkers for cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25:279–84.

    Article  CAS  PubMed  Google Scholar 

  7. Cheon YK, Cho YD, Moon JH, et al. Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy. Am J Gastroenterol. 2007;102:2164–2170.

    Google Scholar 

  8. Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006;11:913–22.

    Article  PubMed  Google Scholar 

  9. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology. 2006;238:150–5.

    Article  PubMed  Google Scholar 

  10. Ringe KI, Wacker F. Radiological diagnosis in cholangiocarcinoma: application of computed tomography, magnetic resonance imaging, and positron emission tomography. Best Pract Res Clin Gastroenterol. 2015;29:253–65.

    Article  PubMed  Google Scholar 

  11. Weber SM, Ribero D, O'Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17:669–80.

    Article  Google Scholar 

  12. Cherqui D, Tantawi B, Alon R, et al. Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg. 1995;130(10):1073–8.

    Article  CAS  PubMed  Google Scholar 

  13. Harrison LE, Fong Y, Klimstra DS, et al. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg. 1998;85(5):1068–70.

    CAS  PubMed  Google Scholar 

  14. Waisberg DR, Pinheiro RS, Nacif LS, et al. Resection for intrahepatic cholangiocellular cancer: new advances. Transl Gastroenterol Hepatol. 2018;3(60).

    Google Scholar 

  15. Thirunavukarasu P, Aloia TA. Preoperative assessment and optimization of the future liver remnant. Surg Clin North Am. 2016;96:197–205.

    Article  PubMed  Google Scholar 

  16. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sulpice L, Rayar M, Boucher E, et al. Intrahepatic cholangiocarcinoma: impact of genetic hemochromatosis on outcome and overall survival after surgical resection. J Surg Res. 2013;180:56–61.

    Article  PubMed  Google Scholar 

  18. Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013;217:126–33.

    Article  PubMed  Google Scholar 

  19. Tanaka K, Matsuo K, Murakami T, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity. Eur J Surg Oncol. 2015;41:506–12.

    Article  CAS  PubMed  Google Scholar 

  20. López-López V, Robles-Campos R, Brusadin R, et al. Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget. 2018;9:28267–80.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Aloia TA. Associating liver partition and portal vein ligation for staged hepatectomy: portal vein embolization should remain the gold standard. JAMA Surg. 2015;150:927–8.

    Article  PubMed  Google Scholar 

  22. Squires MH, Cloyd JM, Dillhoff M, et al. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12:671–81.

    Article  CAS  PubMed  Google Scholar 

  23. Baron TH, Harewood GC, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004;2:214–9.

    Article  PubMed  Google Scholar 

  24. Lang H, Sotiropoulos GC, Fruhauf NR. Extended hepatectomy for intrahepatic cholangiocarcinoma in 50 patients over a 5 year period. Ann Surg. 2005;241(1):134–43.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Isaji S, Kawarada Y, Taoka H, et al. Clinicopathological features and outcomes of hepatic resection for intrahepatic cholangiocarcinoma Japan. J Hepato-Biliary-Pancreat Surg. 1999;6(2):108–16.

    Article  CAS  Google Scholar 

  26. Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg. 2014;149:565–74.

    Article  PubMed  Google Scholar 

  27. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg. 1996;224(5):628.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Casavilla FA, Marsh JW, Iwatsuki S, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185(5):429–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227(1):70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Chu KM, Fan ST. Intrahepatic cholangiocarcinoma in Hong Kong. J Hepato-Biliary-Pancreat Surg. 1999;6(2):149–53.

    Google Scholar 

  31. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern and outcomes. J Am Coll Surg. 2001;193:384–91.

    Article  CAS  PubMed  Google Scholar 

  32. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg. 2002;183(6):679–85.

    Article  PubMed  Google Scholar 

  33. Ohtsuka MH, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89(12):1525–31.

    Article  CAS  PubMed  Google Scholar 

  34. Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29(6):728–33.

    Article  PubMed  Google Scholar 

  35. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Guglielmi A, Ruzzenente A, Campagnaro T, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33(6):1247–54.

    Article  PubMed  Google Scholar 

  37. Lang H, Sotiropoulos GC, Sgourakis G, et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg. 2009;208(2):218–28.

    Article  PubMed  Google Scholar 

  38. Nathan H, Aloia TA, Vauthey JN, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(1):14–22.

    Article  PubMed  Google Scholar 

  39. Shen WF, Zhong W, Xu F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol: WJG. 2009;15(47):5976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.

    Article  PubMed  Google Scholar 

  41. Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer. 2011;117(10):2170–7.

    Article  PubMed  Google Scholar 

  42. Saiura A, Yamamoto J, Kokudo N, et al. Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg. 2011;201(2):203–8.

    Article  PubMed  Google Scholar 

  43. Sriputtha S, Khuntikeo N, Promthet S, Kamsaard S. Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev. 2013;14(2):1107–10.

    Article  PubMed  Google Scholar 

  44. Luo X, Yuan L, Wang Y, et al. Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study. J Gastrointest Surg. 2014;18(3):562–72.

    Article  PubMed  Google Scholar 

  45. Ali SM, Clark CJ, Mounajjed T, et al. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: The Mayo Clinic experience. HPB. 2015;17(3):244–50.

    Article  PubMed  Google Scholar 

  46. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol. 1983;139(2):217–38.

    Article  CAS  PubMed  Google Scholar 

  47. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127(5):498–505.

    Article  CAS  PubMed  Google Scholar 

  48. National Comprehensive Cancer Network (NCCN) guidelines, V 2, 2012. http://www.nccn.org.

  49. Ito K, Ito H, Gonen M, Allen PJ, et al. Adequate lymph node assessment for extrahepatic bile duct cancer: do the data support the current AJCC recommendations?. J Clin Oncol. 2009;27(15_suppl):4576.

    Google Scholar 

  50. Tsuji T, Hiraoka T, Kanemitsu K, et al. Lymphatic spreading pattern of intrahepatic cholangiocarcinoma. Surgery. 2001;129(4):401–7.

    Article  CAS  PubMed  Google Scholar 

  51. Paik KY, Jung JC, Heo JS, et al. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol. 2008;23:766–70.

    Article  PubMed  Google Scholar 

  52. Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31:1188–95.

    Article  PubMed  Google Scholar 

  53. Huang JL, Biehl TR, Lee FT, et al. Outcomes after resection of cholangiocellular carcinoma. Am J Surg. 2004;187(5):612–7.

    Article  PubMed  Google Scholar 

  54. Hasegawa S, Ikai I, Fujii H, et al. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31:1256–63.

    Article  PubMed  Google Scholar 

  55. Zhu AX, Knox JJ. Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues. Oncologist. 2012;17:1504–7.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection. Ann Surg Oncol. 2016;23:235–43.

    Article  PubMed  Google Scholar 

  57. Chu KM, Fan ST. Intrahepatic cholangiocarcinoma in Hong Kong. J Hepato-Biliary-Pancreat Surg. 1999;6(2):149–53.

    Google Scholar 

  58. Fu B, Zhang T, Li H, et al. The role of liver transplantation for intrahepatic cholangiocarcinoma: a single-center experience. Eur Surg Res. 2011;47:218–21.

    Article  PubMed  Google Scholar 

  59. Pichlmayl R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg. 1995;19(1):83–8.

    Article  Google Scholar 

  60. Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg. 1990;77(9):983–7.

    Article  CAS  PubMed  Google Scholar 

  61. O'Grady JG, Polson RJ, Rolles KE, et al. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg. 1988;207(4):373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, Calleja J, Valdivieso A, Valdecasas JC, López P, Gómez M. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239(2):265.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Liver Transplantation Unit, Gastrointestinal Surgery Center, Mansoura University, Mansoura, Egypt

    Mohamed Abdel-Wahab & Ahmed Shehta

Authors
  1. Mohamed Abdel-Wahab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmed Shehta
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Emeritus Professor, The University of Tokyo, Tokyo, Japan

    Masatoshi Makuuchi

  2. National Center for Global Health and Medicine, The University of Tokyo, Tokyo, Japan

    Norihiro Kokudo

  3. “Dan Setlacec” Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania

    Irinel Popescu

  4. Emeritus Professor University Paris Cité, Paris, France

    Jacques Belghiti

  5. Department of Surgery, Seoul National University College of Medicine Seoul National University Bundang Hospital, Seoul, Korea (Republic of)

    Ho-Seong Han

  6. Nagahama City Hospital Network, Shiga, Japan

    Kyoichi Takaori

  7. Massachusetts General Hospital, Harvard Medical School, Boston, USA

    Dan G. Duda

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Abdel-Wahab, M., Shehta, A. (2022). Surgical Management of Intrahepatic Cholangiocarcinoma. In: Makuuchi, M., et al. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-19-0063-1_57

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-0063-1_57

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-0062-4

  • Online ISBN: 978-981-19-0063-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation